Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 244

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 244
---
 |
| Unaudited                                                                  
 Interim Condensed Statements of Comprehensive Loss                         |     | F-3    |
| Unaudited                                                                  
 Interim Condensed Statements of Temporary Equity and Shareholders’ Deficit |     | F-4    |
| Unaudited                                                                  
 Interim Condensed Statements of Cash Flows                                 |     | F-5    |
| Notes                                                                      
 to Unaudited Interim Condensed Financial Statements                        |     | F-6    
 - F-15 |

<div align='center'>- - - - - - - - - - - - - - -

F-1</div>

REGENTIS BIOMATERIALS LTD.

UNAUDITED INTERIM CONDENSED BALANCE SHEETS

U.S. dollars in thousands (except share and per share data)

| Assets                                                                                                                              
 Current assets:                                                                                                                     |     | Note |     | As of    
 June 30, 
 2024     |         |   |     | As of        
 December 31, 
 2023         |         |   |
|:------------------------------------------------------------------------------------------------------------------------------------|:----|-----:|:----|:---------|--------:|:--|:----|:-------------|--------:|:--|
| Cash and cash equivalents                                                                                                           |     |      |     | $        |     176 |   |     | $            |     345 |   |
| Other current assets                                                                                                                |     |      |     |          |      21 |   |     |              |      15 |   |
| Total assets                                                                                                                        |     |      |     | $        |     197 |   |     | $            |     360 |   |
| Liabilities, temporary equity and shareholders’ deficit                                                                             |     |      |     |          |         |   |     |              |         |   |
| Current liabilities:                                                                                                                |     |      |     |          |         |   |     |              |         |   |
| Trade payables                                                                                                                      |     |      |     | $        |     228 |   |     | $            |     353 |   |
| Other accounts payable                                                                                                              |     |    3 |     |          |     733 |   |     |              |   2,576 |   |
| Short-term loan                                                                                                                     |     |    6 |     |          |     150 |   |     |              |     210 |   |